Corautus Genetics Inc. Names Michael K. Steele as Vice President - Business Development


Corautus Genetics Inc. announced Michael K. Steele has joined the Company as Vice President - business development. He will report directly to Richard Otto, President and Chief Executive Officer, and will serve as a corporate officer.

Mr. Steele will have the responsibility of leading Corautus' business development activities, including investor and media relations, business collaboration and partnering opportunities. The result of these activities is anticipated to strengthen and enhance Corautus' product portfolio and competitive position.

Mr. Steele's nearly 20 year professional career includes over 13 years of life science experience in business development, mergers and acquisitions, licensing, operations management and strategy consulting. This includes a number of leadership roles at Serologicals Corporation, his own consultancy practice and most recently as Corporate Vice President with Life Therapeutics Ltd. where he was responsible for leading product licensing, business development and acquisition initiatives. Mr. Steele earned his BS and MBA at James Madison University.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances